Abstract
FK037, a new parenteral cephalosporin, is an oxime-type cephem antibiotic with a 1-hydroxyethyl-5-amino-pyrazole moiety at the 3 position. FK037 was evaluated for antimicrobial activity in vitro and in vivo. In vitro, FK037 was twofold or more active than ceftazidime, cefoperazone, cefotaxime, and ceftriaxone against Pseudomonas aeruginosa (MIC for 90% of the strains [MIC90] = 32 micrograms/ml), members of the family Enterobacteriaceae (MIC90 < or = 2 micrograms/ml), group A streptococci (MIC90 = 0.015 microgram/ml), and methicillin-sensitive or -resistant coagulase-negative staphylococci (MIC90 = 2 and 16 micrograms/ml, respectively). In addition, the activity of FK037 was equal to or greater than that of ceftazidime, cefotaxime, or ceftriaxone against Streptococcus pneumoniae (MIC90 = 0.12 microgram/ml) and methicillin-sensitive or -resistant Staphylococcus aureus (MIC90 = 2 and 16 micrograms/ml, respectively). FK037 was more active in vitro than cefepime (two- to fourfold) and cefpirome (twofold) against S. aureus. In murine systemic infection models, FK037 showed potent activity against P. aeruginosa, Escherichia coli, and methicillin-sensitive and methicillin-resistant S. aureus. FK037 was also efficacious in a mouse model of pyelonephritis caused by S. aureus or Klebsiella pneumoniae and in a mouse model of pneumococcal pneumonia caused by S. pneumoniae. Additional studies on this compound to assess its potential clinical utility are warranted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chin N. X., Gu J. W., Fang W., Neu H. C. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin. Antimicrob Agents Chemother. 1991 Feb;35(2):259–266. doi: 10.1128/aac.35.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fu K. P., Foleno B., Rosenthale M. E. The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin. Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):375–378. doi: 10.1016/0732-8893(92)90028-r. [DOI] [PubMed] [Google Scholar]
- Jacoby G. A., Medeiros A. A. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Sep;35(9):1697–1704. doi: 10.1128/aac.35.9.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. N., Pfaller M. A., Allen S. D., Gerlach E. H., Fuchs P. C., Aldridge K. E. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):361–364. doi: 10.1016/0732-8893(91)90029-f. [DOI] [PubMed] [Google Scholar]
- Neu H. C. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med. 1985 Aug 9;79(2A):2–13. doi: 10.1016/0002-9343(85)90254-2. [DOI] [PubMed] [Google Scholar]